JP2021516953A5 - - Google Patents
Info
- Publication number
- JP2021516953A5 JP2021516953A5 JP2020545324A JP2020545324A JP2021516953A5 JP 2021516953 A5 JP2021516953 A5 JP 2021516953A5 JP 2020545324 A JP2020545324 A JP 2020545324A JP 2020545324 A JP2020545324 A JP 2020545324A JP 2021516953 A5 JP2021516953 A5 JP 2021516953A5
- Authority
- JP
- Japan
- Prior art keywords
- dna vector
- dna
- genes
- polymerase
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023222352A JP2024041819A (ja) | 2018-03-15 | 2023-12-28 | 合成ｄｎａベクターおよびその使用 |
| JP2026050925A JP2026102885A (ja) | 2018-03-15 | 2026-03-25 | 合成ｄｎａベクターおよびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643336P | 2018-03-15 | 2018-03-15 | |
| US62/643,336 | 2018-03-15 | ||
| US201862749369P | 2018-10-23 | 2018-10-23 | |
| US62/749,369 | 2018-10-23 | ||
| PCT/US2019/022511 WO2019178500A1 (en) | 2018-03-15 | 2019-03-15 | Synthetic dna vectors and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222352A Division JP2024041819A (ja) | 2018-03-15 | 2023-12-28 | 合成ｄｎａベクターおよびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021516953A JP2021516953A (ja) | 2021-07-15 |
| JP2021516953A5 true JP2021516953A5 (enExample) | 2022-03-23 |
Family
ID=67908049
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545324A Pending JP2021516953A (ja) | 2018-03-15 | 2019-03-15 | 合成ｄｎａベクターおよびその使用 |
| JP2023222352A Pending JP2024041819A (ja) | 2018-03-15 | 2023-12-28 | 合成ｄｎａベクターおよびその使用 |
| JP2026050925A Pending JP2026102885A (ja) | 2018-03-15 | 2026-03-25 | 合成ｄｎａベクターおよびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222352A Pending JP2024041819A (ja) | 2018-03-15 | 2023-12-28 | 合成ｄｎａベクターおよびその使用 |
| JP2026050925A Pending JP2026102885A (ja) | 2018-03-15 | 2026-03-25 | 合成ｄｎａベクターおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20210002667A1 (enExample) |
| EP (1) | EP3765023A4 (enExample) |
| JP (3) | JP2021516953A (enExample) |
| KR (1) | KR20200132893A (enExample) |
| CN (2) | CN117757842A (enExample) |
| AU (1) | AU2019233901A1 (enExample) |
| CA (1) | CA3092088A1 (enExample) |
| IL (1) | IL276923A (enExample) |
| MX (1) | MX2020009579A (enExample) |
| WO (1) | WO2019178500A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12403305B2 (en) | 2016-06-27 | 2025-09-02 | Galvanize Therapeutics, Inc. | Immunostimulation in the treatment of viral infection |
| DK3474760T3 (da) | 2016-06-27 | 2023-03-20 | Galvanize Therapeutics Inc | Generator og et kateter med en elektrode til at behandle en lungepassage |
| US20200048716A1 (en) * | 2017-11-03 | 2020-02-13 | Twister Biotech, Inc | Using minivectors to treat ovarian cancer |
| EP4552592A3 (en) | 2017-12-26 | 2025-06-18 | Galvanize Therapeutics, Inc. | Optimization of energy delivery for various applications |
| IL326835A (en) * | 2018-10-16 | 2026-04-01 | Blueallele Llc | Methods for targeted insertion of dna genes |
| CN114007535A (zh) | 2019-04-18 | 2022-02-01 | 盖乐世公司 | 用于治疗异常组织的装置、系统和方法 |
| WO2021055760A1 (en) * | 2019-09-18 | 2021-03-25 | Intergalactic Therapeutics, Inc. | Synthetic dna vectors and methods of use |
| CN115348844A (zh) | 2020-04-08 | 2022-11-15 | 盖能适治疗股份有限公司 | 脉冲电场波形操作和使用 |
| CN116829691A (zh) | 2020-08-04 | 2023-09-29 | 盖能适治疗股份有限公司 | 分子到体内细胞的脉冲电场转移 |
| EP4192572A4 (en) | 2020-08-04 | 2024-08-21 | Galvanize Therapeutics, Inc. | TRANSFER OF MOLECULES BY PULSED ELECTRIC FIELD TO CELLS IN THE ORGANISM |
| JP2024509084A (ja) * | 2021-02-23 | 2024-02-29 | インターギャラクティック セラピューティクス インコーポレイテッド | 核酸ベクター及び使用方法 |
| EP4394043A4 (en) * | 2021-08-24 | 2025-09-03 | Cells & Genes Biotech Shanghai Co Ltd | CELL MODIFICATION METHOD |
| AU2022367527A1 (en) * | 2021-10-15 | 2024-05-02 | Aldevron, Llc | Respiratory delivery of therapeutic agents |
| KR20250011939A (ko) * | 2022-05-13 | 2025-01-22 | 아시디엔 테라퓨틱스, 인크. | Abca4 트랜스-스플라이싱 분자 |
| JP2025525583A (ja) | 2022-07-19 | 2025-08-05 | ランパート バイオサイエンス インコーポレイテッド | 非免疫原性環状非ウイルス性ｄｎａベクター |
| KR20250034991A (ko) | 2022-08-16 | 2025-03-11 | 알데브론 엘엘씨 | 합성 환형 핵산 생산을 위한 무세포 방법 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5478745A (en) * | 1992-12-04 | 1995-12-26 | University Of Pittsburgh | Recombinant viral vector system |
| US6825012B2 (en) * | 1995-02-23 | 2004-11-30 | Gencell S.A. | DNA molecules, preparation and use in gene therapy |
| CN1264854C (zh) * | 1999-05-28 | 2006-07-19 | 坎布雷科斯生物科学巴尔的摩公司 | Dna纯化方法和纯化的dna |
| EP1224313A1 (en) * | 1999-10-07 | 2002-07-24 | University of Iowa Research Foundation | Adeno-associated viruses and uses thereof |
| EP1317560A4 (en) * | 2000-09-08 | 2005-10-05 | Gen Hospital Corp | DNA VECTORS WHICH COULD REENGANIZE |
| US20070196838A1 (en) * | 2000-12-08 | 2007-08-23 | Invitrogen Corporation | Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| US20030082559A1 (en) * | 2001-01-19 | 2003-05-01 | David Beach | Methods and reagents for amplification and manipulation of vector and target nucleic acid sequences |
| AU2009231171A1 (en) * | 2008-04-02 | 2009-10-08 | Fondazione Telethon | Method of treating genetic disorders |
| US8945885B2 (en) * | 2008-07-03 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Minicircle DNA vector preparations and methods of making and using the same |
| CN102083975A (zh) * | 2008-07-03 | 2011-06-01 | 利兰·斯坦福青年大学托管委员会 | 小环dna载体制剂及其制备方法和使用方法 |
| EP2439276A1 (de) * | 2010-10-05 | 2012-04-11 | Rentschler Biotechnologie GmbH | Verfahren zur semi-synthetischen Herstellung hochreiner "MiniCircle" DNA-Vektoren aus Plasmiden |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| US20140350087A9 (en) * | 2012-03-22 | 2014-11-27 | Halozyme, Inc. | Oncovector Nucleic Acid Molecules and Methods of Use |
| US10604771B2 (en) * | 2013-05-10 | 2020-03-31 | Sangamo Therapeutics, Inc. | Delivery methods and compositions for nuclease-mediated genome engineering |
| AU2015264263B2 (en) * | 2014-05-20 | 2021-08-05 | University Of Iowa Research Foundation | Huntington's disease therapeutic compounds |
| EP3250685A1 (en) * | 2015-01-27 | 2017-12-06 | F. Hoffmann-La Roche AG | Recombinant hbv cccdna, the method to generate thereof and the use thereof |
| AU2016260401B2 (en) * | 2015-05-14 | 2022-05-19 | St. Jude Children's Research Hospital, Inc. | Nucleic acid molecules containing spacers and methods of use thereof |
| AU2016355343C1 (en) * | 2015-11-19 | 2024-10-03 | Lloyd G. Mitchell | Compositions and methods for correction of heritable ocular disease |
| IL261524B2 (en) * | 2016-03-03 | 2023-10-01 | Univ Massachusetts | End-capped linear double-stranded DNA for non-viral gene transfer |
| WO2021055760A1 (en) * | 2019-09-18 | 2021-03-25 | Intergalactic Therapeutics, Inc. | Synthetic dna vectors and methods of use |
-
2019
- 2019-03-15 MX MX2020009579A patent/MX2020009579A/es unknown
- 2019-03-15 JP JP2020545324A patent/JP2021516953A/ja active Pending
- 2019-03-15 CA CA3092088A patent/CA3092088A1/en active Pending
- 2019-03-15 EP EP19766752.0A patent/EP3765023A4/en active Pending
- 2019-03-15 CN CN202311181118.4A patent/CN117757842A/zh active Pending
- 2019-03-15 AU AU2019233901A patent/AU2019233901A1/en not_active Abandoned
- 2019-03-15 KR KR1020207028218A patent/KR20200132893A/ko not_active Ceased
- 2019-03-15 US US16/980,914 patent/US20210002667A1/en not_active Abandoned
- 2019-03-15 CN CN201980019118.XA patent/CN111954528A/zh active Pending
- 2019-03-15 WO PCT/US2019/022511 patent/WO2019178500A1/en not_active Ceased
-
2020
- 2020-08-25 IL IL276923A patent/IL276923A/en unknown
-
2023
- 2023-12-28 JP JP2023222352A patent/JP2024041819A/ja active Pending
-
2024
- 2024-04-04 US US18/626,384 patent/US20240247284A1/en active Pending
-
2026
- 2026-03-25 JP JP2026050925A patent/JP2026102885A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022549138A5 (enExample) | ||
| JP2022517174A5 (enExample) | ||
| JP2023126487A5 (enExample) | ||
| CN112154208B (zh) | 产生改进的病毒和非病毒纳米质粒载体 | |
| EP3242903B1 (en) | Compositions for introducing nucleic acid into cells | |
| ES2344078T3 (es) | Arnm estabilizado con un contenido de g/c aumentado para la terapia genetica. | |
| GB2643666A (en) | Linear dna with enhanced resistance against exonucleases and methods for the production thereof | |
| JP2025061660A (ja) | Ｒｎａ誘導型エンドヌクレアーゼを使用するｄｎａ組み込みのための改善された方法 | |
| JP2019524149A5 (enExample) | ||
| JP2021516953A (ja) | 合成ｄｎａベクターおよびその使用 | |
| JP2018527013A5 (enExample) | ||
| JP2023511991A5 (enExample) | ||
| JP2023526310A5 (enExample) | ||
| JP2024516272A (ja) | エキソヌクレアーゼに対する増加した耐性を有する直鎖状ｄｎａ | |
| US20250223592A1 (en) | Compositions and methods for circular rna affinity purification | |
| KR20240126447A (ko) | 원형 dna 벡터의 합성 생산 | |
| WO2025102994A1 (zh) | 基于i型内含子的rna体外环化与滚环翻译的方法及其应用 | |
| CN113950530A (zh) | 核酸多联体产物的表达 | |
| JP2024502620A5 (enExample) | ||
| WO2024015803A9 (en) | Encrypted rna and methods of its use | |
| WO2018139637A1 (ja) | 核酸封入ａａｖ中空粒子 | |
| CN115806984A (zh) | 环状rna及载体和载体的应用 | |
| US12116578B2 (en) | Methods and systems of PCR-based recombinant adeno-associated virus manufacture | |
| WO2022068884A1 (zh) | 核酸递送方法及系统 | |
| JP7642824B2 (ja) | 遺伝子発現および抑制が同時に可能な核酸構造体 |